{"product_id":"global-angiography-devices-market-size-study-forecast-by-device-computed-tomography-ct-angiography-devices-magnetic-resonance-angiography-mra-devices-x-ray-angiography-devices-by-product-catheter-tubes-angiography-systems-balloons-guidewir","title":"Global Angiography Devices Market Size study \u0026 Forecast, by Device (Computed Tomography (CT), Angiography Devices, Magnetic Resonance Angiography (MRA) Devices, X-ray Angiography Devices), by Product (Catheter Tubes, Angiography Systems, Balloons Guidewir","description":"\u003cp\u003eGlobal Angiography Devices Market Size study \u0026amp; Forecast, by Device (Computed Tomography (CT), Angiography Devices, Magnetic Resonance Angiography (MRA) Devices, X-ray Angiography Devices), by Product (Catheter Tubes, Angiography Systems, Balloons Guidewires, Vascular Closure Devices, Guidewires, Contrast Media, Accessories), by Procedure (Coronary Angiography, Micro-angiography, Non-coronary Angiography, Others), by Application (Diagnostics, Therapeutics), By Indication (Known \u0026amp; Suspected Coronary Artery Disease (CAD), Congenital Heart Disease, Congestive Heart Failure, Valvular Heart Disease, Others), By End-User (Diagnostic Centers, Hospitals, Academic Research Laboratories) and Regional Analysis, 2022-2029\u003c\/p\u003e\n\n\u003cp\u003eGlobal Angiography Devices Market is valued at approximately USD 11409.32 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2022-2029. The medical devices and instruments used for imaging and diagnostics are called angiography devices. A medical procedure known as angiograms makes it possible to image the lumen of blood vessels such as arteries and veins as well as the chambers of the heart and other body organs. These are also known as low-risk vascular imaging devices. The key factors driving the market growth are rising aging population and incidence of cardiovascular diseases. Also, another factor driving the market growth is rising government investments in healthcare infrastructure that creates lucrative demand for the market.\u003c\/p\u003e\n\n\u003cp\u003eAccording to the World Health Organization, over 17.9 million deaths worldwide occur in 2017, as a result of cardiovascular diseases, and by 2030, this number is expected to rise to over 23.6 million. As a result, the prevalence of cardiovascular diseases is boosting the market for angiography devices, which could gradually result in the market's growth. Also, rising demand for interventional angiography systems in minimally invasive surgeries would create lucrative opportunities for the market during forecast period. However, the poor reimbursement policies and high cost of angiography stifle market growth throughout the forecast period of 2022-2029.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Angiography Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising geriatric population and prevalence of cardiovascular diseases and presence of key companies in the U.S. attributed to the major share of the market.  Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising favorable government reimbursement policies, technological advancements, and rising investment in healthcare sector.\u003c\/p\u003e\n\n\u003cp\u003eMajor market players included in this report are:\u003cbr\u003e\nToshiba Medical Systems Corporation\u003cbr\u003e\nSt. Jude Medical, Inc.\u003cbr\u003e\nSiemens AG\u003cbr\u003e\nShimadzu Corporation\u003cbr\u003e\nMedtronic Plc\u003cbr\u003e\nKoninklijke Philips N.V.\u003cbr\u003e\nGeneral Electric Company\u003cbr\u003e\nJohnson \u0026amp; Johnson\u003cbr\u003e\nBoston Scientific Corporation\u003cbr\u003e\nAbbott Laboratories\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\n? In April 2022, GE Healthcare launched its new product, the \"\"Discovery IGSTM 740 mobile angiography system.\"\" The untethered Discovery IGS 740 offers seating flexibility and room design. Users may experience superior comfort and control due to the rail-free design and flexible wide bore C-arm positioning of the Discovery. Additionally, both in 2D and 3D, its large detector covers large anatomies.\u003cbr\u003e\n? In 2021, Royal Philips introduced its perception for interventional drugs by integrating its breakthrough spectral CT imaging technology into a hybrid Angio CT suite. Through the combination of its unique Spectral CT 7500 system and its Image-Guided Therapy System – Azurion with FlexArm into a single interventional suite solution, Philips aims to provide interventionalists with rapid table-side access to these two significant imaging modalities.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Angiography Devices Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Device, Product, Procedure, Application, Indication, End-User, Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e\n\n\u003cp\u003eBy Device\u003cbr\u003e\nComputed Tomography (CT)\u003cbr\u003e\nAngiography Devices\u003cbr\u003e\nMagnetic Resonance Angiography (MRA) Devices\u003cbr\u003e\nX-ray Angiography Devices\u003c\/p\u003e\n\n\u003cp\u003eBy Product\u003cbr\u003e\nCatheter Tubes\u003cbr\u003e\nAngiography Systems\u003cbr\u003e\nBalloons Guidewires\u003cbr\u003e\nVascular Closure Devices\u003cbr\u003e\nGuidewires\u003cbr\u003e\nContrast Media\u003cbr\u003e\nAccessories\u003c\/p\u003e\n\n\u003cp\u003eBy Procedure\u003cbr\u003e\nCoronary Angiography\u003cbr\u003e\nMicro-angiography\u003cbr\u003e\nNon-coronary Angiography\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy Application:\u003cbr\u003e\nDiagnostics\u003cbr\u003e\nTherapeutics\u003c\/p\u003e\n\n\u003cp\u003eBy Indication:\u003cbr\u003e\nKnown \u0026amp; Suspected Coronary Artery Disease (CAD)\u003cbr\u003e\nCongenital Heart Disease\u003cbr\u003e\nCongestive Heart Failure\u003cbr\u003e\nValvular Heart Disease\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBy End-User:\u003cbr\u003e\nDiagnostic Centers\u003cbr\u003e\nHospitals\u003cbr\u003e\nAcademic Research Laboratories\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nROLA\u003cbr\u003e\nRest of the World\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eToshiba Medical Systems Corporation\u003cbr\u003e\nSt. Jude Medical, Inc.\u003cbr\u003e\nSiemens AG\u003cbr\u003e\nShimadzu Corporation\u003cbr\u003e\nMedtronic Plc\u003cbr\u003e\nKoninklijke Philips N.V.\u003cbr\u003e\nGeneral Electric Company\u003cbr\u003e\nJohnson \u0026amp; Johnson\u003cbr\u003e\nBoston Scientific Corporation\u003cbr\u003e\nAbbott Laboratories\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"December, 2022 \/ 200 Pages \/ MCW16234217","offer_id":47650865447218,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-angiography-devices-market-size-study-forecast-by-device-computed-tomography-ct-angiography-devices-magnetic-resonance-angiography-mra-devices-x-ray-angiography-devices-by-product-catheter-tubes-angiography-systems-balloons-guidewir","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}